354 related articles for article (PubMed ID: 23931057)
1. Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia.
McKee MD; Hoac B; Addison WN; Barros NM; Millán JL; Chaussain C
Periodontol 2000; 2013 Oct; 63(1):102-22. PubMed ID: 23931057
[TBL] [Abstract][Full Text] [Related]
2. Biological stenciling of mineralization in the skeleton: Local enzymatic removal of inhibitors in the extracellular matrix.
Reznikov N; Hoac B; Buss DJ; Addison WN; Barros NMT; McKee MD
Bone; 2020 Sep; 138():115447. PubMed ID: 32454257
[TBL] [Abstract][Full Text] [Related]
3. Insights into dental mineralization from three heritable mineralization disorders.
Chavez MB; Kramer K; Chu EY; Thumbigere-Math V; Foster BL
J Struct Biol; 2020 Oct; 212(1):107597. PubMed ID: 32758526
[TBL] [Abstract][Full Text] [Related]
4. Mineral tessellation in bone and the stenciling principle for extracellular matrix mineralization.
McKee MD; Buss DJ; Reznikov N
J Struct Biol; 2022 Mar; 214(1):107823. PubMed ID: 34915130
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific mineralization defects in the periodontium of the Hyp mouse model of X-linked hypophosphatemia.
Coyac BR; Falgayrac G; Baroukh B; Slimani L; Sadoine J; Penel G; Biosse-Duplan M; Schinke T; Linglart A; McKee MD; Chaussain C; Bardet C
Bone; 2017 Oct; 103():334-346. PubMed ID: 28764922
[TBL] [Abstract][Full Text] [Related]
6. Abnormal osteopontin and matrix extracellular phosphoglycoprotein localization, and odontoblast differentiation, in X-linked hypophosphatemic teeth.
Salmon B; Bardet C; Coyac BR; Baroukh B; Naji J; Rowe PS; Opsahl Vital S; Linglart A; Mckee MD; Chaussain C
Connect Tissue Res; 2014 Aug; 55 Suppl 1():79-82. PubMed ID: 25158186
[TBL] [Abstract][Full Text] [Related]
7. Role of PHOSPHO1 in Periodontal Development and Function.
Zweifler LE; Ao M; Yadav M; Kuss P; Narisawa S; Kolli TN; Wimer HF; Farquharson C; Somerman MJ; Millán JL; Foster BL
J Dent Res; 2016 Jul; 95(7):742-51. PubMed ID: 27016531
[TBL] [Abstract][Full Text] [Related]
8. Contributions of increased osteopontin and hypophosphatemia to dentoalveolar defects in osteomalacic Hyp mice.
Mohamed FF; Hoac B; Phanrungsuwan A; Tan MH; Giovani PA; Ghiba S; Murshed M; Foster BL; McKee MD
Bone; 2023 Nov; 176():116886. PubMed ID: 37634682
[TBL] [Abstract][Full Text] [Related]
9. Enzyme replacement therapy prevents dental defects in a model of hypophosphatasia.
McKee MD; Nakano Y; Masica DL; Gray JJ; Lemire I; Heft R; Whyte MP; Crine P; Millán JL
J Dent Res; 2011 Apr; 90(4):470-6. PubMed ID: 21212313
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin regulates dentin and alveolar bone development and mineralization.
Foster BL; Ao M; Salmon CR; Chavez MB; Kolli TN; Tran AB; Chu EY; Kantovitz KR; Yadav M; Narisawa S; Millán JL; Nociti FH; Somerman MJ
Bone; 2018 Feb; 107():196-207. PubMed ID: 29313816
[TBL] [Abstract][Full Text] [Related]
11. Hypophosphatasia-associated deficiencies in mineralization and gene expression in cultured dental pulp cells obtained from human teeth.
Rodrigues TL; Foster BL; Silverio KG; Martins L; Casati MZ; Sallum EA; Somerman MJ; Nociti FH
J Endod; 2012 Jul; 38(7):907-12. PubMed ID: 22703652
[TBL] [Abstract][Full Text] [Related]
12. Periodontal Defects in the A116T Knock-in Murine Model of Odontohypophosphatasia.
Foster BL; Sheen CR; Hatch NE; Liu J; Cory E; Narisawa S; Kiffer-Moreira T; Sah RL; Whyte MP; Somerman MJ; Millán JL
J Dent Res; 2015 May; 94(5):706-14. PubMed ID: 25716980
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of mineralization and the role of alkaline phosphatase in health and disease.
Orimo H
J Nippon Med Sch; 2010 Feb; 77(1):4-12. PubMed ID: 20154452
[TBL] [Abstract][Full Text] [Related]
14. MEPE-derived ASARM peptide inhibits odontogenic differentiation of dental pulp stem cells and impairs mineralization in tooth models of X-linked hypophosphatemia.
Salmon B; Bardet C; Khaddam M; Naji J; Coyac BR; Baroukh B; Letourneur F; Lesieur J; Decup F; Le Denmat D; Nicoletti A; Poliard A; Rowe PS; Huet E; Vital SO; Linglart A; McKee MD; Chaussain C
PLoS One; 2013; 8(2):e56749. PubMed ID: 23451077
[TBL] [Abstract][Full Text] [Related]
15. Correction of hypophosphatasia-associated mineralization deficiencies in vitro by phosphate/pyrophosphate modulation in periodontal ligament cells.
Rodrigues TL; Foster BL; Silverio KG; Martins L; Casati MZ; Sallum EA; Somerman MJ; Nociti FH
J Periodontol; 2012 May; 83(5):653-63. PubMed ID: 22014174
[TBL] [Abstract][Full Text] [Related]
16. Defective Mineralization in X-Linked Hypophosphatemia Dental Pulp Cell Cultures.
Coyac BR; Hoac B; Chafey P; Falgayrac G; Slimani L; Rowe PS; Penel G; Linglart A; McKee MD; Chaussain C; Bardet C
J Dent Res; 2018 Feb; 97(2):184-191. PubMed ID: 28880715
[TBL] [Abstract][Full Text] [Related]
17. Molecular determinants of extracellular matrix mineralization in bone and blood vessels.
Murshed M; McKee MD
Curr Opin Nephrol Hypertens; 2010 Jul; 19(4):359-65. PubMed ID: 20489614
[TBL] [Abstract][Full Text] [Related]
18. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.
Rowe PS
Crit Rev Eukaryot Gene Expr; 2012; 22(1):61-86. PubMed ID: 22339660
[TBL] [Abstract][Full Text] [Related]
19. Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl-/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase.
Gasque KC; Foster BL; Kuss P; Yadav MC; Liu J; Kiffer-Moreira T; van Elsas A; Hatch N; Somerman MJ; Millán JL
Bone; 2015 Mar; 72():137-47. PubMed ID: 25433339
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage.
Addison WN; Masica DL; Gray JJ; McKee MD
J Bone Miner Res; 2010 Apr; 25(4):695-705. PubMed ID: 19775205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
